COLGATE TOTAL Drug Patent Profile

Which patents cover Colgate Total, and when can generic versions of Colgate Total launch?

Colgate Total is a drug marketed by Colgate Palmolive and is included in one NDA.

The generic ingredient in COLGATE TOTAL is sodium fluoride; triclosan. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium fluoride; triclosan profile page.

Summary for COLGATE TOTAL

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	4
Clinical Trials:	31
Patent Applications:	413
DailyMed Link:	COLGATE TOTAL at DailyMed

Recent Clinical Trials for COLGATE TOTAL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Universidade Federal do Para	Phase 3
University of Baghdad	Phase 3
University of California, San Francisco	Early Phase 1

See all COLGATE TOTAL clinical trials

US Patents and Regulatory Information for COLGATE TOTAL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997		DISCN	Yes	No

Expired US Patents for COLGATE TOTAL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997

International Patents for COLGATE TOTAL

See the table below for patents covering COLGATE TOTAL around the world.

Country	Patent Number	Title	Estimated Expiration
Greece	890100853
Hong Kong	102594	Antibacterial, antiplaque, anticalculus oral composition
United Kingdom	2230189	ANTIBACTERIAL,ANTIPLAQUE,ANTICALCULUS ORAL COMPOSITION
India	168400	ANTIBACTERIAL ANTIPLAQUE,ANTICALCULUS ORAL COMPOSITION
Hungary	T59302

Supplementary Protection Certificates for COLGATE TOTAL

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1912999	1490062-5	Sweden		PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
1856135	CA 2020 00018	Denmark		PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE, SOLVATE OR N-OXIDE OF FOSTAMATINIB OR THE PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REG. NO/DATE: EU/1/19/1405 20200113
2822954	LUC00083	Luxembourg		PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM; AUTHORISATION NUMBER AND DATE: EU/1/18/1289 20180625
1856135	LUC00153	Luxembourg		PRODUCT NAME: FOSTAMATINIB OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE FOSTAMATINIB, OU UN HYDRATE, SOLVATE OU N-OXYDE DE FOSTAMATINIB OU LE SEL PHARMACEUTIQUEMENT ACCEPTABLE DE FOSTAMATINIB, EN PARTICULIER FOSTAMATINIB DISODIUM, EVENTUELLEMENT SOUS FORME D'HYDRATE; AUTHORISATION NUMBER AND DATE: EU/1/19/1405 20200113
1948158	1690020-1	Sweden		PRODUCT NAME: SACUBITRIL AND VALSARTAN, AS SACUBITRIL VALSARTAN SODIUM SALT COMPLEX, I.E. TRISODIUM 3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3- ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-(S)-3-METHYL-2- (PENTANOYL2-(TETRAZOL-5-YLATE)BIPHENYL-4- YLMETHYLAMINO)BUTYRATE HEMIPENTAHYDRATE; REG. NO/DATE: EU/1/15/1058 20151123